Selective inhibitor of the bone morphogenic protein (BMP) ALK2 receptor (IC50
= 108 nM). Exhibits no detectable inhibition of AMPK, ALK5, KDR (VEGFR-2) or PDGFRβ
receptors. Blocks BMP4-induced phosphorylation of Smads 1, 5 and 8 in HEK293 cells. Promotes neurogenesis in human induced pluripotent stem cells (iPSCs) when used in combination with SB 431542
(Cat. No. 1614).
Soluble to 20 mM in DMSO
Store at +4°C
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Swimming into the future of drug discovery: in vivo chemical screens in zebrafish.
Bowman and Zon
ACS Chem.Biol., 2010;5:159
DMH1, a highly selective small molecule BMP inhibitor, promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction.
Neely et al.
ACS Chem.Neurosci., 2012;3:482
In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors.
Hao et al.
ACS Chem.Biol., 2010;5:245
The citations listed below are publications that use Tocris products. Selected citations for DMH-1 include:
Showing Results 1 - 8 of 8